Belgium· BE-AMP-SAM273971-00

Concentré d'Antithrombine III Baxalta 500 IU

A antithrombin iii product containing human antithrombin iii, registered in Belgium by Baxalta Innovations. The same ATC class is registered in 11 of our 19 countries.

ATC B01AB02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about human antithrombin iiiAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Antithrombin iii is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AB02 (antithrombin iii), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
6 of them publish a price we can compare per daily dose

Search antithrombin iii products by name

Antithrombin iii · ATC B01AB02

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Human Antithrombin III
Manufacturer: Baxalta Innovations
Country: Belgium (BE)
ATC code: B01AB02
ATC class: Antithrombin III
Defined daily dose: 2.1 TSD, E
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
0783530
be_apb
2357051

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for antithrombin iii.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check antithrombin iii against other medicines How interaction checks work

Antithrombin iii · interactions on record

112 records

41 severe
71 moderate

Most severe, free to view

DalteparinB01AB04severe
EnoxaparinB01AB05severe
DanaparoidB01AB09severe
TinzaparinB01AB10severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Antithrombin iii in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All antithrombin iii products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Antithrombin Iii Takeda, Atenativ
Bulgaria · Антитромбин Iii Nf Получен От Човешка Плазма Баксалта, Атенатив
Czechia · Anbinex, Antithrombin Iii Baxalta
Germany · Anbinex, Atenativ
Denmark · Antitrombin Iii Baxalta, Atenativ
Estonia · Atenativ
Spain · Anbinex, Kybernin P
Finland · Atenativ
France · Aclotine, Atenativ
Greece · Kybernin P
Croatia · Antithrombin Iii Baxalta, Atenativ
Hungary · Antithrombin Iii Baxalta, Atenativ
Italy · Anbinex, Anternaty
Lithuania · Atenativ
Luxembourg · Kybernin P
Latvia · Atenativ
Malta · Antithrombin Iii Baxalta
Netherlands · Antitrombine Iii Concentraat Baxalta, Atenativ
Norway · Atenativ
Poland · Anbinex, Antithrombin Iii Nf Takeda
Portugal · Anbinex, Atenativ
Romania · Atenativ
Sweden · Antithrombin Iii Baxalta, Antithrombin Iii Octapharma
Slovenia · Atenativ, Kybernin P
Slovakia · Anbinex, Antithrombin Iii Ľudský Antitrombín Iii Získaný Z Plazmy Baxalta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c482a1e5-9628-487a-9608-9a6a1b8ab66e
GET /v1/drugs/c482a1e5-9628-487a-9608-9a6a1b8ab66e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Concentré d'Antithrombine III Baxalta 500 IU",
  "name_fr": "Concentré d'Antithrombine III Baxalta 500 IU",
  "name_nl": "Antithrombine III-Concentraat Baxalta 500 IU",
  "amp_code": "SAM273971-00",
  "strengths": [
    "500.0000",
    "100.0000",
    "90.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Human Antithrombin III",
    "Glucose",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Antithrombin III",
  "authorisation_numbers": [
    "BE273971"
  ]
}

API reference MCP server Plans

See everything about antithrombin iii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console